Emergency Medicine Doctors in Mcminnville, OR Accepting Medicare

9 Emergency Medicine doctors found. Showing 1 - 9

Dr. Mark Rose, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2700 Se Stratus Ave, Mcminnville, OR 97128 Phone: 503-472-6131

Dr. Helge R Berg, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2700 Se Stratus Ave, Mcminnville, OR 97128 Phone: 503-472-6131

Dr. Paul Daniel Dale, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 207 Ne 19th St, Mcminnville, OR 97128 Phone: 503-435-1077

Dr. Ricardo Carlon, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Se Stratus Ave, Mcminnville, OR 97128 Phone: 503-472-6131

Dr. Francisco Arroyo, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2700 Se Stratus Ave, Mcminnville, OR 97128 Phone: 503-472-6131

Dr. Thomas Cronin, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Se Stratus Ave, Mcminnville, OR 97128 Phone: 503-435-3551

Dr. Janet Paquette, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2700 Se Stratus Ave, Mcminnville, OR 97128 Phone: 503-472-6131

Dr. John Robert Sandberg, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2700 Se Stratus Ave, Mcminnville, OR 97128 Phone: 503-472-6131

Dr. Jack Vining, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2700 Se Stratus Ave, Mcminnville, OR 97128 Phone: 503-472-6131

News Archive

COMP issues positive opinion for Celsion's ThermoDox Orphan Drug Designation

Celsion Corporation, a leading oncology drug development company, today announced that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has issued a positive opinion on the application for Orphan Drug Designation for ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, for the treatment of hepatocellular carcinoma (HCC), commonly referred to as primary liver cancer.

Elevation presents positive data from EP-101 Phase 2a study on COPD at ERS annual meeting

Elevation Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of new aerosol therapies for patients with respiratory diseases, announced today that it presented positive results from a Phase 2a study of EP-101 in patients with moderate to severe chronic obstructive pulmonary disease (COPD), a large and growing disease characterized by significant unmet clinical needs, at the annual meeting of the European Respiratory Society.

Exploring the Future of Breast Cancer Risk Assessment

An interview with Dr Gareth Evans about the future of breast cancer screening and the implementation of single nucleotide polymorphism (SNP) profiling.

Overutilization of medical imaging services increases unnecessary radiation exposure: Report

Overutilization of medical imaging services exposes patients to unnecessary radiation and adds to healthcare costs, according to a report appearing online and in the October issue of the journal Radiology that calls on radiologists to spearhead a collaborative effort to curb imaging overutilization.

The Human Brain Project successfully enters the third phase

"This is a major step and the result of a lot of hard and excellent work by our members and partners all over Europe", says the HBPs Scientific Director, Katrin Amunts, a medical doctor and neuroscientist based at Forschungszentrum Jülich and Full Professor for Brain Research at Heinrich Heine University Düsseldorf in Germany.

Read more Medical News

› Verified 6 days ago